From Scale to Spend: The GLP-1 Surge

Traditional drug spending in the U.S. has surpassed specialty drug spending, and the primary force behind this trend is GLP-1 receptor agonists. These incretin-based therapies are transforming both the clinical and economic landscapes, from diabetes to obesity.

In this episode of the Center for Pharmacy Practice Excellence’s VerifiedRx podcast, host Tori Richie, Senior Consulting Director of Intelligence at Sg2 is joined by Vizient colleagues Stacy Lauderdale, AVP of Evidence-Based Medicine, Heather Pace, Senior Clinical Manager of Ambulatory Care, and Emily Fitt, Intelligence Consultant at Sg2. They delve into a comprehensive discussion on GLP-1s, covering topics from telehealth services and patient management strategies to the unique attributes that set these therapies apart.

Grab your coffee and get comfortable. This isn’t just a conversation; it’s a front-row seat to how GLP-1s are reshaping the future of obesity management.

 

Guest speakers: 

Stacy Lauderdale, Pharm.D, BCPS

Associate Vice President

Vizient Center for Pharmacy Practice Excellence

VerifiedRx Host

 

Heather Pace, Pharm.D

Sr. Clinical Manager of Ambulatory Care,

Vizient Center for Pharmacy Practice Excellence

 

Emily Fitt, MHA, MPH

Consultant

Sg2

 

Host: 

Tori Richie

Senior Consulting Director, Intelligence

Sg2

Sg2 Perspectives Host

 

Show Notes: 

[02:24-04:50] How GLP-1 medications differ from traditional treatments and shift from use in diabetes to obesity management

[04:51-05:54] The most common side effects of GLP-1 therapies and how clinicians can effectively manage patients

[05:55-08:49] Treatment teams for obesity management and the role of the pharmacist in the management of GLP-1 medications

[08:50-10:51] Challenges providers face integrating GLP-1 medications into practice

[10:16-13:20] Quality or outcome concerns with individuals who receive GLP-1 medications from telehealth providers

[13:21-15:01] Trends shaping this landscape

[15:02-21:14] Best practices that providers should deploy

 

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Spotify

Android

RSS Feed